πŸ‡ΊπŸ‡Έ FDA
Patent

US 8785460

Tricyclic compounds and use thereof

granted A61KA61K31/4188A61K31/519

Quick answer

US patent 8785460 (Tricyclic compounds and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/4188, A61K31/519, A61P, A61P25/00